Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis

BACKGROUND: Concurrent cisplatin with radiotherapy (CRT) or concurrent cetuximab with radiotherapy (BRT) improves outcomes in locally advanced head and neck squamous cell carcinoma (HNSCC) compared with radiotherapy alone. Nevertheless, a detailed comparison between CRT and BRT in locally advanced H...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wen-Hua, Sun, Wei, Long, Guo-Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478598/
https://www.ncbi.nlm.nih.gov/pubmed/32899005
http://dx.doi.org/10.1097/MD.0000000000021785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478598/
https://www.ncbi.nlm.nih.gov/pubmed/32899005
http://dx.doi.org/10.1097/MD.0000000000021785

Ejemplares similares